Literature DB >> 24346427

[Hypnotics--state of the science].

C Nissen1, L Frase, G Hajak, T C Wetter.   

Abstract

This article provides an overview of the indications and effects of sleep-inducing drugs. Pharmacological treatment should only be considered in cases of insufficient response to non-pharmacological interventions. Benzodiazepines and benzodiazepine receptor agonists are indicated for the short-term treatment of acute insomnia. Due to the risk of tolerance and dependency, sedative antihistamines and antidepressants are widely used as long-term hypnotics. Other substances, including herbal compounds and melatonin have few side effects; however, the therapeutic efficacy is very limited. Currently, long-term data on the efficacy and tolerability of sleep-inducing substances are lacking. Specifically in cases of non-response to first line treatment, extended psychiatric and somatic evaluation and treatment of associated disorders are recommended.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24346427     DOI: 10.1007/s00115-013-3893-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  23 in total

Review 1.  Hypothalamic regulation of sleep and circadian rhythms.

Authors:  Clifford B Saper; Thomas E Scammell; Jun Lu
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

2.  Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials.

Authors:  Maria Isabel Fernández-San-Martín; Roser Masa-Font; Laura Palacios-Soler; Pilar Sancho-Gómez; Cristina Calbó-Caldentey; Gemma Flores-Mateo
Journal:  Sleep Med       Date:  2010-03-26       Impact factor: 3.492

3.  Slow wave sleep-inducing effects of first generation H1-antagonists.

Authors:  K Saitou; Y Kaneko; Y Sugimoto; Z Chen; C Kamei
Journal:  Biol Pharm Bull       Date:  1999-10       Impact factor: 2.233

4.  Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.

Authors:  G Hajak; A Rodenbeck; U Voderholzer; D Riemann; S Cohrs; F Hohagen; M Berger; E Rüther
Journal:  J Clin Psychiatry       Date:  2001-06       Impact factor: 4.384

5.  A two process model of sleep regulation.

Authors:  A A Borbély
Journal:  Hum Neurobiol       Date:  1982

6.  Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.

Authors:  D Riemann; U Voderholzer; S Cohrs; A Rodenbeck; G Hajak; E Rüther; M H Wiegand; G Laakmann; T Baghai; W Fischer; M Hoffmann; F Hohagen; G Mayer; M Berger
Journal:  Pharmacopsychiatry       Date:  2002-09       Impact factor: 5.788

7.  Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans.

Authors:  D J Dijk; C A Czeisler
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 8.  The hyperarousal model of insomnia: a review of the concept and its evidence.

Authors:  Dieter Riemann; Kai Spiegelhalder; Bernd Feige; Ulrich Voderholzer; Mathias Berger; Michael Perlis; Christoph Nissen
Journal:  Sleep Med Rev       Date:  2009-05-28       Impact factor: 11.609

9.  The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium.

Authors:  Wallace B Mendelson; Thomas Roth; James Cassella; Timothy Roehrs; James K Walsh; James H Woods; Daniel J Buysse; Roger E Meyer
Journal:  Sleep Med Rev       Date:  2004-02       Impact factor: 11.609

10.  Short-term training increases diagnostic and treatment rate for insomnia in general practice.

Authors:  Jutta Backhaus; Klaus Junghanns; Kristin Mueller-Popkes; Andreas Broocks; Dieter Riemann; Goeran Hajak; Fritz Hohagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2002-06       Impact factor: 5.270

View more
  3 in total

1.  Sleep-Related Disorders in Neurology and Psychiatry.

Authors:  Jan Rémi; Thomas Pollmächer; Kai Spiegelhalder; Claudia Trenkwalder; Peter Young
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

2.  [The contributions by Emil Kraepelin to the knowledge on sleep disorders and their treatment].

Authors:  K Becker; M Kluge; H Steinberg
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

3.  [Insomnia--state of the science].

Authors:  D Riemann; C Baglioni; B Feige; K Spiegelhalder
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.